The effect of ketamine anesthesia on the immune function of mice with postoperative septicemia.
BACKGROUND
It is unknown how ketamine anesthesia immunologically affects the outcome of patients with postoperative septicemia. We investigated the effects of ketamine anesthesia on mice with an Escherichia coli or lipopolysaccharide (LPS) challenge after laparotomy, focusing on phagocytosis by liver macrophages (Kupffer cells) and cytokine production.


METHODS
C57BL/6 mice received ketamine or sevoflurane anesthesia during laparotomy, which was followed by an E. coli or LPS challenge; thereafter, mouse survival rates and cytokine secretions were examined. The effects of a β-adrenoceptor antagonist, nadolol, on ketamine anesthesia were also assessed to clarify the mechanisms of ketamine-induced immunosuppressive effects.


RESULTS
Ketamine anesthesia increased the mouse survival rate after LPS challenge after laparotomy compared with sevoflurane anesthesia, whereas such an effect of ketamine was not observed after E. coli challenge. Ketamine suppressed tumor necrosis factor (TNF) and interferon (IFN)-γ secretion after LPS and E. coli challenge. When bacterial growth was inhibited using an antibiotic, ketamine anesthesia effectively improved mouse survival after E. coli challenge compared with sevoflurane anesthesia. Neutralization of TNF also improved survival and decreased IFN-γ secretion after bacterial challenge in antibiotic-treated mice with sevoflurane anesthesia, suggesting that ketamine's suppression of TNF may improve survival. Ketamine also suppressed in vivo phagocytosis of microspheres by Kupffer cells in LPS-challenged mice. Concomitant use of nadolol with an anesthetic dose of ketamine did not restore TNF suppression in LPS-challenged mice, suggesting a mechanism independent of the β-adrenergic pathway. However, it restored TNF secretion under low-dose ketamine (10% anesthetic dose). In contrast, nadolol restored the decrease in phagocytosis by Kupffer cells, which was induced by the anesthetic dose of ketamine via the β-adrenergic pathway, suggesting distinct mechanisms.


CONCLUSIONS
Ketamine suppresses TNF production and phagocytosis by Kupffer cells/macrophages. Therefore, unless bacterial growth is well controlled (by an antibiotic), postoperative infection might not improve despite reduction of the inflammatory response.
Takahashi
Tetsuya
T
Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, 359-8613 Japan.
Kinoshita
Manabu
M
Shono
Satoshi
S
Habu
Yoshiko
Y
Ogura
Takahiro
T
Seki
Shuhji
S
Kazama
Tomiei
T
D000758:Anesthesia; D000818:Animals; D016207:Cytokines / Q000378:metabolism; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development; D004927:Escherichia coli Infections / Q000276:immunology / Q000382:microbiology / Q000401:mortality; D007649:Ketamine / Q000008:administration & dosage*; D007813:Laparotomy / Q000009:adverse effects; D008070:Lipopolysaccharides / Q000008:administration & dosage; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage; D051379:Mice; D008810:Mice, Inbred C57BL; D011183:Postoperative Complications / Q000276:immunology* / Q000378:metabolism / Q000401:mortality; D018805:Sepsis / Q000276:immunology* / Q000378:metabolism / Q000401:mortality; D000077149:Sevoflurane
D016207:Cytokines; D008070:Lipopolysaccharides; D008738:Methyl Ethers; D000077149:Sevoflurane; D007649:Ketamine